LINDSAY BOLL: Open Payments
NPI 1912452863 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 20 payments from 12 companies in 2025. Trend: 2023 $830 · 2024 $692 · 2025 $561
Food & beverage: $461Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $121 |
| Amgen Inc. | 3 | $75 |
| ABBVIE INC. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Incyte Corporation | 2 | $47 |
| Kerecis Limited | 1 | $46 |
| UCB, Inc. | 1 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $29 |
| GENZYME CORPORATION | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
Products named: TREMFYA, DUPIXENT, Otezla, SKYRIZI, OPZELURA, Kerecis SurgiClose, Bimzelx, Zoryve.
Industry payments across MI — which companies pay providers there.
